The IVDR Transition Period May Be Extended Beyond May 2022
The EU Commission has finally recognised the potential for IVDR to cause significant disruption in the supply of IVD’s and has listened to the increasingly loud clamour for an extension from across healthcare providers and industry.
As a result, the European Commission has proposed to delay the implementation of certain aspects of the In Vitro Diagnostic Medical Devices Regulation (IVDR).